These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16204468)

  • 21. G protein coupling and ligand selectivity of the D2L and D3 dopamine receptors.
    Lane JR; Powney B; Wise A; Rees S; Milligan G
    J Pharmacol Exp Ther; 2008 Apr; 325(1):319-30. PubMed ID: 18218829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of rat dopamine D2 receptor occupancy for a series of antipsychotic drugs measured using radiolabeled or nonlabeled raclopride tracer.
    Barth VN; Chernet E; Martin LJ; Need AB; Rash KS; Morin M; Phebus LA
    Life Sci; 2006 May; 78(26):3007-12. PubMed ID: 16434058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A consideration of the dopamine D2 receptor monomer-dimer equilibrium and the anomalous binding properties of the dopamine D2 receptor ligand, N-methyl spiperone.
    Logan J; Fowler JS; Dewey SL; Volkow ND; Gatley SJ
    J Neural Transm (Vienna); 2001; 108(3):279-86. PubMed ID: 11341479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine D2 receptor partial agonists display differential or contrasting characteristics in membrane and cell-based assays of dopamine D2 receptor signaling.
    Jordan S; Johnson JL; Regardie K; Chen R; Koprivica V; Tadori Y; Kambayashi J; Kitagawa H; Kikuchi T
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):348-56. PubMed ID: 17070976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Competitive MS binding assays for dopamine D2 receptors employing spiperone as a native marker.
    Niessen KV; Höfner G; Wanner KT
    Chembiochem; 2005 Oct; 6(10):1769-75. PubMed ID: 16149041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonist.
    Heinrich JN; Brennan J; Lai MH; Sullivan K; Hornby G; Popiolek M; Jiang LX; Pausch MH; Stack G; Marquis KL; Andree TH
    Eur J Pharmacol; 2006 Dec; 552(1-3):36-45. PubMed ID: 17056032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concentration of receptor and ligand revisited in a modified receptor binding protocol for high-affinity radioligands: [3H]Spiperone binding to D2 and D3 dopamine receptors.
    Zhen J; Antonio T; Dutta AK; Reith ME
    J Neurosci Methods; 2010 Apr; 188(1):32-8. PubMed ID: 20122961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet dopamine: D2 receptor binding in patients with migraine.
    Shukla R; Khanna VK; Vinod P; Sankhwar ML; Yadav RS
    Cephalalgia; 2009 May; 29(5):532-8. PubMed ID: 19170695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine D2High receptors measured ex vivo are elevated in amphetamine-sensitized animals.
    Seeman P
    Synapse; 2009 Mar; 63(3):186-92. PubMed ID: 19086090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrostatic surface potential calculation on several new halogenated benzimidazole-like dopaminergic ligands.
    Sukalović V; Andrić D; Roglić G; Kostić-Rajaccić S; Soskić V
    Arch Pharm (Weinheim); 2004 Jul; 337(7):376-82. PubMed ID: 15237387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms for metoclopramide-mediated sensitization and haloperidol-induced catalepsy in rats.
    Agovic MS; Yablonsky-Alter E; Lidsky TI; Banerjee SP
    Eur J Pharmacol; 2008 Jun; 587(1-3):181-6. PubMed ID: 18457824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sigma1 and dopamine D2 receptor occupancy in the mouse brain after a single administration of haloperidol and two dopamine D2-like receptor ligands.
    Ishiwata K; Kawamura K; Kobayashi T; Matsuno K
    Nucl Med Biol; 2003 May; 30(4):429-34. PubMed ID: 12767400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oligomers of D2 dopamine receptors: evidence from ligand binding.
    Strange PG
    J Mol Neurosci; 2005; 26(2-3):155-60. PubMed ID: 16012188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine D2(High) receptors on intact cells.
    Seeman P
    Synapse; 2008 Apr; 62(4):314-8. PubMed ID: 18241049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Constitutive oligomerization of human D2 dopamine receptors expressed in Spodoptera frugiperda 9 (Sf9) and in HEK293 cells. Analysis using co-immunoprecipitation and time-resolved fluorescence resonance energy transfer.
    Gazi L; López-Giménez JF; Rüdiger MP; Strange PG
    Eur J Biochem; 2003 Oct; 270(19):3928-38. PubMed ID: 14511374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and binding profile of constrained analogues of N-[4-(4-arylpiperazin-1-yl)butyl]-3-methoxybenzamides, a class of potent dopamine D3 receptor ligands.
    Leopoldo M; Lacivita E; Colabufo NA; Berardi F; Perrone R
    J Pharm Pharmacol; 2006 Feb; 58(2):209-18. PubMed ID: 16451749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ligand-dependent oligomerization of dopamine D(2) and adenosine A(2A) receptors in living neuronal cells.
    Vidi PA; Chemel BR; Hu CD; Watts VJ
    Mol Pharmacol; 2008 Sep; 74(3):544-51. PubMed ID: 18524886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine/serotonin receptor ligands. 10: SAR Studies on azecine-type dopamine receptor ligands by functional screening at human cloned D1, D2L, and D5 receptors with a microplate reader based calcium assay lead to a novel potent D1/D5 selective antagonist.
    Hoefgen B; Decker M; Mohr P; Schramm AM; Rostom SA; El-Subbagh H; Schweikert PM; Rudolf DR; Kassack MU; Lehmann J
    J Med Chem; 2006 Jan; 49(2):760-9. PubMed ID: 16420061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and activity of 2-[4-(4-[3H]-2-cyanophenyl)piperazinyl]-N-(2,4,6-[3H]3-3-methylphenyl)acetamide: a selective dopamine D4 receptor agonist and radioligand.
    Matulenko MA; Surber B; Fan L; Kolasa T; Nakane M; Terranova MA; Uchic ME; Miller LN; Chang R; Donnelly-Roberts DL; Namovic MT; Moreland RB; Brioni JD; Stewart AO
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5095-8. PubMed ID: 15380206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: I. Receptor-binding profile and functional actions at G-protein-coupled receptors.
    Millan MJ; Mannoury la Cour C; Novi F; Maggio R; Audinot V; Newman-Tancredi A; Cussac D; Pasteau V; Boutin JA; Dubuffet T; Lavielle G
    J Pharmacol Exp Ther; 2008 Feb; 324(2):587-99. PubMed ID: 18024789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.